Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
STALLION IND FLUOROCHEM L

STALLION IND FLUOROCHEM L

NSE: STALLION
Specialty ChemicalsBasic MaterialsSMALL CAPMCap ₹2.49k Cr
₹214.43₹-5.19 (-2.36%)

Market Closed • NSE

Market cap₹2.49k Cr
Enterprise value₹2.15k Cr
P/E TTM40.23
P/B2.59
EPS TTM₹5.33
D/E5.07
Dividend yield0.00%
52W high₹423.80
52W low₹99.32
Price chart(1Y)
1Y Return:+12.92% (+₹24.53)
H: ₹279L: ₹170.58
1W-4.53%
1M-8.46%
3M+5.56%
6M+45.84%
1Y-30.13%
Today at a glance

Day range

₹212.80₹223.85

52 week range

₹99.32₹423.80
Volume437.7K1.46x 20D avg
Free float50.00%+46.00% volume

STALLION IND FLUOROCHEM L closed at INR214.43 (-2.36%) on volume 1.46x its 20-day average, trading 49.4% below its 52-week high.

Technical analysis
RSI (14)43.6Neutral (30–70)
MACDBEARISHBearish (Below signal)
ATR (14)₹10.90High
SMA 20₹222.95BEARISH
SMA 50₹228.91BEARISH
SMA 100₹213.54BULLISH
SMA 200₹186.39BULLISH
CPR bottom₹222.46
Pivot₹221.51
CPR top₹220.57
What changed recently?

2026-Q1

Q1 FY2026 Financial Results

PAT moved -1.7% QoQ

2026-02-11

RIGHTS Announced

Rights 19:41 @ Premium Rs 89/-

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PASS4/4 criteria
Shariah Compliant
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹34.5 Cr₹2.49k Cr1.39%≤ 33%PASS
Non-halal income ratio–₹430.7 Cr0.00%≤ 5%PASS
Illiquid assets ratio₹524.6 Cr₹737.0 Cr71.17%≥ 20%PASS
Receivables ratio–₹737.0 Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E40.2321.40
Forward P/E——
P/B2.592.20
EV/EBITDA—18.00
PEG—1.00
Earnings yield2.504.70
Growth & profitability
RevenuePAT
FY23PAT margin 4.30%
FY24PAT margin 6.60%
FY25PAT margin 8.60%
FY26PAT margin 10.20%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y+24.10%
Revenue CAGR 5Y—
PAT CAGR 3Y+65.00%
PAT CAGR 5Y—
Operating margin17.83%
Net margin11.78%
Financial health & cash flow
Net debt–Moderate
Interest coverage63.50xEBIT / interest
CFO / PAT-0.52x3Y average
Net debt / EBITDA—Leverage
Operating cash flow₹39.4 Cr
Capital expenditure–
Free cash flow₹-995.5 Lakh
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall65/100
Valuation50/100
Profitability50/100
Financial health95/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Low Debt Profile: Debt-to-Equity is comfortable at 0.05x

Risks

Subject to cyclical raw material and macro industry pressures

Bull case

Market Leadership: Established operational scale in Specialty Chemicals.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · September 2025

Ownership distribution

Sept 2025Latest holding

Category trends

Hover over a period for exact holdings

60%40%20%0%Jun 2025Sept 2025
2.35%Institutional holding
49.84%Public holding
2Periods available
0.00%Promoter pledged
64.15KShareholders
Corporate Action

Complete dividend, bonus, split, rights and other action history

Record dateCorporate actionInformationAnnouncement dateEx-date
11 Feb 2026Rights issueRights 19:41 @ Premium Rs 89/-—11 Feb 2026
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

8 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
UltraTech Cement Limited
UltraTech Cement LimitedULTRACEMCO
Open analysis
₹3.14L36.802.30%₹25,799.47₹2,982.76+11.86%+20.17%
JSW Steel Limited
JSW Steel LimitedJSWSTEEL
Open analysis
₹2.85L11.520.60%₹47,364.00₹4,651.00+11.55%+112.96%
Hindustan Zinc Limited
Hindustan Zinc LimitedHINDZINC
Open analysis
₹2.30L13.462.07%₹13,687.00₹5,425.00+77.22%+146.14%
Asian Paints Limited
Asian Paints LimitedASIANPAINT
Open analysis
₹2.24L47.081.19%₹10,541.94₹1,539.25+17.94%+39.96%
Tata Steel Limited
Tata Steel LimitedTATASTEEL
Open analysis
₹2.17L19.642.33%₹60,794.00₹2,385.00+14.32%+18.83%
Hindalco Industries Limited
Hindalco Industries LimitedHINDALCO
Open analysis
₹2.00L12.210.56%₹84,825.00₹7,013.00+32.06%+75.15%
Grasim Industries Limited
Grasim Industries LimitedGRASIM
Open analysis
₹1.96L34.470.35%₹11,794.71₹246.65-70.60%-82.61%
Solar Industries India Limited
Solar Industries India LimitedSOLARINDS
Open analysis
₹1.81L90.880.06%₹3,668.00₹666.00+70.29%+88.67%
About STALLION IND FLUOROCHEM L
STALLION IND FLUOROCHEM L

Incorporated in 2002, Stallion India Fluorochemicals Limited is engaged in selling Refrigerant and Industrial Gases and related products.[1]

IndiaBasic Materials

Questions investors ask
Is STALLION IND FLUOROCHEM L Shariah compliant?

STALLION IND FLUOROCHEM L is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (1.39%) complies with AAOIFI threshold (≤ 33%).

What is STALLION IND FLUOROCHEM L's current valuation relative to peers?

STALLION IND FLUOROCHEM L trades at a P/E of 40.2x compared to the sector median of 21.4x, and a Price-to-Book of 2.6x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 0.05x. Interest coverage is 63.5x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.